These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11077233)

  • 1. Menopause and depression: a review of psychologic function and sex steroid neurobiology during the menopause(1).
    Richardson TA; Robinson RD
    Prim Care Update Ob Gyns; 2000 Nov; 7(6):215-223. PubMed ID: 11077233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.
    Soares CN; Poitras JR; Prouty J
    Drugs Aging; 2003; 20(2):85-100. PubMed ID: 12534310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHEA, important source of sex steroids in men and even more in women.
    Labrie F
    Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood disorders and menopause.
    Pearlstein T; Rosen K; Stone AB
    Endocrinol Metab Clin North Am; 1997 Jun; 26(2):279-94. PubMed ID: 9193884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hormone replacement therapy and antidepressant use in peri- and postmenopausal women.
    Gartrell NK; Koh AS; Becker C; LaVoy A; Rosen S; Thiemann S
    J Gend Specif Med; 2001; 4(1):60-3. PubMed ID: 11324242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroids, reproductive endocrine function, and affect. A review.
    Frye CA
    Minerva Ginecol; 2009 Dec; 61(6):541-62. PubMed ID: 19942840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAMS/Solvay Resident Essay Award. Relationship between estrogen, serotonin, and depression.
    Archer JS
    Menopause; 1999; 6(1):71-8. PubMed ID: 10100184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy: indications and complications.
    Judd HL; Meldrum DR; Deftos LJ; Henderson BE
    Ann Intern Med; 1983 Feb; 98(2):195-205. PubMed ID: 6824255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex hormones and headache.
    Silberstein SD
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife.
    Bosworth HB; Bastian LA; Kuchibhatla MN; Steffens DC; McBride CM; Skinner CS; Rimer BK; Siegler IC
    Psychosom Med; 2001; 63(4):603-8. PubMed ID: 11485114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood scores in relation to hormone replacement therapies during menopause: a prospective randomized trial.
    Onalan G; Onalan R; Selam B; Akar M; Gunenc Z; Topcuoglu A
    Tohoku J Exp Med; 2005 Nov; 207(3):223-31. PubMed ID: 16210834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Climacteric: concept, consequence and care.
    Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression and the menopause: why antidepressants are not enough?
    Graziottin A; Serafini A
    Menopause Int; 2009 Jun; 15(2):76-81. PubMed ID: 19465674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
    Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS
    JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen use and depressive symptoms in postmenopausal women.
    Palinkas LA; Barrett-Connor E
    Obstet Gynecol; 1992 Jul; 80(1):30-6. PubMed ID: 1603493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
    Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.